Non-profit · founded 1946
Oklahoma Medical Research Foundation
Oklahoma City, United States · omrf.org
- Citations, last 5 years
- 16.2k
- Works, last 5 years
- 1 568
- h-index
- 435
- Scientists listed
- 0
- Grants since 2016
- 602
Grants received
2022–2027 · research · R01
Complement C5 inhibition as sepsis therapy
Florea Lupu · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2022–2026 · research · R01
Increasing glycolysis in the diabetic heart is cardioprotective and improves glucose tolerance
Kenneth M Humphries · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2022–2027 · grant · DP5
Sex chromosomal regulation of hippocampal microglial activation with Alzheimer's disease and aging
Sarah Renee Ocanas · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2022–2027 · research · R01
Interrogating the intersection between diet and ocular autoimmunity
Scott M Plafker · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2022–2027 · research · R01
A novel role for oxidized lipid mediators as effectors of muscle atrophy and weakness in aging
Holly Van Remmen · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2022–2026 · research · R01
Novel lymphatic genes that regulate heart valve development and disease
Rajanarayanan S Srinivasan · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2022 · fellowship · Postdoctoral Fellowship
Regulation of HK2-driven glycolysis in lymphatic vascular development
Gregoire Manaud · Oklahoma Medical Research Foundation · funded by American Heart Association
2022–2024 · research · R21
Functional Analysis of GWAS loci associated with hearing loss.
Gaurav K Varshney · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2022–2026 · research · R01
Determining the context specificity of metformin treatment on muscle mitochondria and healthspan
Benjamin Francis Miller · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2022–2027 · research · R01
A novel role for oxidized lipid mediators as effectors of muscle atrophy and weakness in aging
Holly Van Remmen · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2022–2026 · research · R01
Increasing glycolysis in the diabetic heart is cardioprotective and improves glucose tolerance
Kenneth M Humphries · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2022–2026 · cooperative agreement · UC2
Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core
Joel Marvin Guthridge · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2022–2026 · cooperative agreement · UC2
Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core
Joel Marvin Guthridge · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2022–2024 · research · R21
Connecting the gap between GWAS and functional targets for lupus susceptibility
Swapan K. Nath · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2022–2025 · research · R21
Connecting the gap between GWAS and functional targets for lupus susceptibility
Swapan K. Nath · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2022–2027 · grant · DP5
Sex chromosomal regulation of hippocampal microglial activation with Alzheimer's disease and aging
Sarah Renee Ocanas · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2022–2027 · research · R35
The role of mitochondrial regulation in cell lineage specification and function
Meng Zhao · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2022–2027 · research · R01
Complement C5 inhibition as sepsis therapy
Florea Lupu · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2022–2027 · research · R01
Complement C5 inhibition as sepsis therapy
Florea Lupu · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2022–2025 · research · R21
Functional Analysis of GWAS loci associated with hearing loss.
Gaurav K Varshney · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2022–2027 · research · R35
The role of mitochondrial regulation in cell lineage specification and function
Meng Zhao · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2022–2026 · cooperative agreement · UC2
Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core
Joel Marvin Guthridge · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2022–2026 · research · R01
Novel lymphatic genes that regulate heart valve development and disease
Rajanarayanan S Srinivasan · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2022–2025 · research · R21
Investigating the role of SIRT3 in metabolic flexibility and proteostasis in the aging heart
Kenneth M Humphries · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2022–2027 · research · R01
Interrogating the intersection between diet and ocular autoimmunity
Scott M Plafker · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2022–2027 · research · R01
Metabolic mechanisms controlling lymphatic vessel formation
Pengchun Yu · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2022 · research · R01
Equipment Supplement for Centromere Interactions and Meiotic Chromosome Segregation in Yeast
Dean S Dawson · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2022–2026 · cooperative agreement · UC2
Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core
Joel Marvin Guthridge · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2022–2027 · research · R01
Interrogating the intersection between diet and ocular autoimmunity
Scott M Plafker · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2022–2027 · research · R01
A novel role for oxidized lipid mediators as effectors of muscle atrophy and weakness in aging
Holly Van Remmen · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2022–2027 · research · R01
Dissecting the integrated mechanisms of protein turnover to prevent proteostatic decline with aging
Benjamin Francis Miller · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2022–2027 · research · R35
The role of mitochondrial regulation in cell lineage specification and function
Meng Zhao · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2022–2027 · grant · DP5
Sex chromosomal regulation of hippocampal microglial activation with Alzheimer's disease and aging
Sarah Renee Ocanas · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2022–2027 · grant · DP5
Sex chromosomal regulation of hippocampal microglial activation with Alzheimer's disease and aging
Sarah Renee Ocanas · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2022–2027 · research · R01
Interrogating the intersection between diet and ocular autoimmunity
Scott M Plafker · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2022–2027 · research · R01
Metabolic mechanisms controlling lymphatic vessel formation
Pengchun Yu · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2022–2026 · research · R01
Determining the context specificity of metformin treatment on muscle mitochondria and healthspan
Benjamin Francis Miller · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2022–2026 · cooperative agreement · UC2
Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core
Joel Marvin Guthridge · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2022–2027 · research · R01
Complement C5 inhibition as sepsis therapy
Florea Lupu · Oklahoma Medical Research Foundation · funded by National Institutes of Health
2022–2026 · research · R01
Increasing glycolysis in the diabetic heart is cardioprotective and improves glucose tolerance
Kenneth M Humphries · Oklahoma Medical Research Foundation · funded by National Institutes of Health